¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary adhesion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitreoretinal adhesion
    À¯¸®Ã¼¸Á¸·À¯Âø
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary
    ÀÏÂ÷-, ¿ø¹ß-
  • primary action
    ÀÏÂ÷ÀÛ¿ë
  • primary affect hunger
    ÀÏÂ÷Á¤µ¿°¥¸Á, ÀÏÂ÷¾ÖÁ¤°¥¸Á
  • primary aldosteronism
    ¿ø¹ß¾Ëµµ½ºÅ×·ÐÁõ
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ
  • primary amnion
    ÀÏÂ÷¾ç¸·, ¿ø½Ã¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ÀÏÂ÷¹æ¼ö, ¿ø¹æ¼ö
  • primary atelectasis
    ¿ø¹ß¹«±âÆó
  • primary atypical pneumonia
    ¿ø¹ßºñÁ¤ÇüÆó·Å
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intercellular adhesion molecule
    ¼¼Æ÷°£ºÎÂøºÐÀÚ
  • vascular cell adhesion molecule
    Ç÷°ü¼¼Æ÷À¯ÂøºÐÀÚ
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ, ÀÏÂ÷¹«¿ù°æ
  • primary amnion
    ¿ø½Ã¾ç¸·, ÀÏÂ÷¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ¿ø¹æ¼ö, ÀÏÂ÷¹æ¼ö
  • primary olfactory receiving area
    ÀÏÂ÷Èİ¢¿µ¿ª
  • primary sensory area
    ÀÏÂ÷°¨°¢±¸¿ª
  • primary bronchus
    ÀÏÂ÷±â°üÁö
  • primary membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • primary cancer
    ¿ø¹ß¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾
  • primary cardiomyopathy
    ¿ø¹ß½ÉÀå±ÙÀ°º´Áõ
  • primary cement
    ÀÏÂ÷½Ã¸àÆ®Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • infection, primary
    ÀÏÂ÷°¨¿°
  • interaction, primary
    ÀÏÂ÷»óÈ£ÀÛ¿ë
  • pneumonia, primary atypical
    ¿ø¹ß¼º ºñÁ¤ÇüÆó·Å
  • premaxilla [primary palate]
    ¾ÕÀ§ÅλÀ (ÀÏÂ÷ÀÔõÀå)
  • primary
    ¿ø¹ß¼º(ê«Û¡àõ)ÀÇ
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
  • primary action
    ÀÏÂ÷±â´É
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • primary adaptation
    ÀÏÂ÷(¼º) ¼øÀÀ(ìéó­àõâ÷ëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • conjunctival adhesion
    °á¸·À¯Âø
  • endothelial adhesion molecule
    ³»ÇǼººÎÂøºÐÀÚ
  • endothelial leukocyte adhesion molecule
    ³»ÇǼ¼Æ÷¹éÇ÷±¸ À¯ÂøºÐÀÚ
  • fibrous adhesion
    ¼¶À¯¼ºÀ¯Âø
  • fibrous adhesion
    ¼¶À¯¼º À¯Âø.
  • intercellular adhesion molecule 1(icam-1)
    ¼¼Æ÷°£(á¬øàÊà) Á¢ÂøºÐÀÚ(ïÈó·ÝÂí­) 1 (ICAM-1)
  • intercellular adhesion molecule-1 (ICAM-1)
    ¼¼Æ÷°£ À¯ÂøºÐÀÚ-1
  • interthalamic adhesion
    Áß°£µ¢ÀÌ, Áß°£±«(ñéÊàÎÔ).
  • interthalamic adhesion
    ½Ã»ó»çÀ̺ÙÀ½
  • labial adhesion
    À½¼øÀ¯Âø
  • leukocyte adhesion deficiency
    ¹éÇ÷±¸ Á¢Âø °áÇÌ(¡­ ïÈó· ÌÀù¹)
  • leukocyte adhesion deficiency =LAD
    ¹éÇ÷±¸ ºÎÂø °áÇÌÁõ
  • leukocyte adhesion molecule-1=LAM
    ¹éÇ÷±¸ ºÎÂø ºÐÀÚ-1
  • omental adhesion syndrome
    ´ë¸Á¸·À¯ÂøÁõÈıº(´ë¸Á¸·À¯ÂøÁõÈıº).
  • omental adhesion syndrome
    ´ë¸Á¸·À¯ÂøÁõÈıº(ÓÞØÑØ¯ë¨ó·ñøý¦ÏØ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Primary follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary cephalic vein
    ÀÏÂ÷¸Ó¸®Á¤¸Æ
    [¿¾ ¿ë¾î] ÀÏÂ÷µÎÁ¤¸Æ
  • Primary capillary network
    ÀÏÂ÷¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð¼¼Ç÷°ü¸Á
  • Primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÏÂ÷Àûº¹ºÎÂø»ó
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary osteon
    ÀÏÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¿ø
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý·Ú
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÇü¼º¾Æ
  • Primary ossification center
    ÀÏÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary ossification center [Diaphyseal ossification center]
    ÀÏÂ÷»À¹ß»ýÁ᫐ [»À¸öÅë¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary trilaminar cortex
    ÀÏÂ÷»ïÃþÆÇ°ÑÁú
    [¿¾ ¿ë¾î] ÀÏÂ÷»ïÃþÆÇÇÇÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary deficiency
    ¿ø¹ß¼º °áÇÌ(ê«Û¡àõÌÀù¹)
  • primary derived protein
    ÀÏÂ÷ À¯µµ ´Ü¹éÁú(ìéó­ë¯ÓôÓ±ÛÜòõ)
  • primary filament
    ÀÏÂ÷(ìéó­) Çʶó¸àÆ®
  • primary fluor
    ÀÏÂ÷ Çü±¤Ã¼(ìéó­û«ÎÃô÷)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • primary ionization
    ÀÏÂ÷(ìéó­) ÀÌ¿ÂÈ­(ûù)
  • primary isotope effect
    ÀÏÂ÷ µ¿À§¿ø¼Ò È¿°ú(ìéó­ÔÒêÈêªáÈüùÍý)
  • primary lysosome
    ÀÏÂ÷(ìéó­) ¶óÀ̼ÒÁ»
  • primary messenger
    ÀÏÂ÷ Àü·É(ìéó­îîÖµ)
  • primary metabolite
    ÀÏÂ÷ ´ë»ç¹°Áú(ìéó­ÓÛÞóÚªòõ)
  • primary oxaluria
    ¿ø¹ß¼º(ê«Û¡àõ) ¿Á»ì»ê´¢Áõ(Òãñø)
  • primary pigment
    ÀÏÂ÷ »ö¼Ò(ìéó­ßäáÈ)
  • primary plot
    ÀÏÂ÷(ìéó­) Ç÷Ô
  • primary prostaglandin
    ÀÏÂ÷(ìéó­) ÇÁ·Î½ºÅ¸±Û¶õµò
  • primary protein derivative
    ÀÏÂ÷ ´Ü¹éÁúÀ¯µµÃ¼
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary tumor
    ¿ù¹ßÁ¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PH parathyroid hormone; partial hepatectomy; partial hysterectomy; passive hemagglutination; past histo...
PHC personal health costs; posthospital care; premolar hypodontia, hyperhidrosis, [premature] canities [...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
ICAMs Inter-Cellular Adhesion Molecules
ADAM amniotic deformity, adhesion, mutilation [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AMOG Adhesion molecule on glia
AM Adhesion molecules
ICAM Anti-intercellular adhesion molecule
ICAM-1 Anti-intercellular adhesion molecule-1
BLAD Bovine Leukocyte Adhesion Deficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • A alpha primary afferent
    A ¾ËÆÄ ÀÏÂ÷ ±¸½É ½Å°æ
    ±Ù¹æÃß ³»ÀÇ ±Ù ¼¶À¯¿¡ Á¸ÀçÇÏ´Â °¨°¢½Å°æÀÇ Çϳª·Î ¥°a °¨°¢ ½Å°æÀ̶ó°íµµ ÇÑ´Ù. Á÷°æÀº 22§­, Àüµµ ¼Óµµ´Â 120§½ÀÌ´Ù.
  • C primary afferent nociceptor
    C ÀÏÂ÷ ±¸½É¼º Ä§ÇØ ¼ö¿ëü, C ÀÏÂ÷ ±¸½É¼º À¯ÇØ ¼ö¿ë±â
  • early primary closure
    Á¶±â 1Â÷ ºÀÇÕ
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • myelinated primary afferent
    ÀÏÂ÷ À¯¼öÃÊ ±¸½É ½Å°æ
  • nociceptive primary afferent
    Ä§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ, À¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive A delta C primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ, ºñÀ¯ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive myelinated primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯, ºñÀ¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary
    ÀÏÂ÷¼º, ¿ø¹ß¼º, ¿ø¹ß¼ºÀÇ, ÀÏÂ÷, ÀÏÂ÷ÀÇ, ÀÏÂ÷¼ºÀÇ, Á¦ÀÏÀÇ, ÃʱâÀÇ, ¿ø¹ßÀÇ, ÁÖµÈ
    ¹ß»ýµÇ´Â ½Ã±âÀÇ ¼ø¼­¿¡ À־ óÀ½ÀÎ.
  • primary adaptation
    ÀÏÂ÷ ¼øÀÀ, ÀÏÂ÷¼º ¼øÀÀ
  • primary adrenocortical insuffciency
    ¿ø¹ß¼º ºÎ½Å ÇÇÁú ±â´É ºÎÀü
  • primary afferent axon
    ÀÏÂ÷ ±¸½É¼º Ãà»è
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primary afferent fiber
    ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary afferent nociceptive transmitter
    ÀÏÂ÷ ±¸½É À¯ÇØ ¼ö¿ë¼º Àü´Þ ¹°Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cell adhesion molecules, neuron-glia Cell adhesion molecules that mediate neuron-neuron adhesion and neuron-astrocyte adhesion. They are expressed on neurons and schwann cells, but not astrocytes and are involved in neuronal migration, neurite fasciculation, and outgrowth. Ng-cam is immunologically and structurally distinct from ncam (neural cell adhesion molecules).
(12 Dec 1998)
water of adhesion Water held by molecular attraction in contact with solid surfaces, but not forming an essential part of their constitution.
(05 Mar 2000)
secondary adhesion Delayed closure of two granulating surfaces.
Synonym: secondary adhesion, secondary union.
(05 Mar 2000)
neural cell adhesion molecule See: NCAM.
(18 Nov 1997)
differential adhesion The differential adhesion hypothesis was advanced by Steinberg to explain the mechanism by which heterotypic cells in mixed aggregates sort out into isotypic territories. Quantitative differences in homo and hetero typic adhesion are supposed to be sufficient to account for the phenomenon without the need to postulate cell type specific adhesion systems: fairly generally accepted, although some tissue specific cell adhesion molecules are now known to exist.
(18 Nov 1997)
immune adhesion test The diagnostic application of the immune adhesion phenomenon.
Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test.
(05 Mar 2000)
intercellular adhesion molecule See: ICAM.
(18 Nov 1997)
intercellular adhesion molecule-1 <chemical> A cell-surface ligand with a role in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.
Chemical name: Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)
(12 Dec 1998)
interthalamic adhesion The variable connection between the two thalamic masses across the third ventricle; absent in about 20% of human brains.
Synonym: adhesio interthalamica, commissura cinerea, commissura grisea, intermediate mass, massa intermedia.
(05 Mar 2000)
endothelial-leukocyte adhesion molecule 115,000 Mw molecule on the surface of endothelial cells that is involved in blood leukocyte attachment to vessel walls as well as emigration from the vessels into the tissues.
(05 Mar 2000)
fibrinous adhesion An adhesion that consists of fine threads of fibrin resulting from an exudate of plasma or lymph, or an extravasation of blood.
(05 Mar 2000)
fibrous adhesion Fibrous strands resulting from the organization of fibrinous adhesion's.
(05 Mar 2000)
focal adhesion <cell biology> Areas of close apposition and thus presumably anchorage points, of the plasma membrane of a fibroblast (for example) to the substratum over which it is moving.
Usually 1m x 0.2 m with the long axis parallel to the direction of movement, always associated with a cytoplasmic microfilament bundle that is attached via several proteins to the plasma membrane at an area of high protein concentration (this is noticeably electron dense in electron micrographs). Focal adhesions tend to be characteristic of slow moving cells.
(18 Nov 1997)
leukocyte adhesion deficiency An inherited disorder (autosomal recessive) in which there is a defective CD18 adherence complex that disturbs leukocyte chemotaxis. It is characterised by recurrent bacterial infections and impaired wound healing.
(05 Mar 2000)
leukocyte-adhesion deficiency syndrome <syndrome> Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (receptors, leukocyte-adhesion) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterised by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary colors
    ¿ø»ö(»¡°­,³ë¶û,ÆÄ¶û)
  • primary consumer
    Á¦1Â÷ ¼ÒºñÀÚ(ÃÊ½Ä µ¿¹°)
  • primary coolant
    (¿øÀÚ·ÎÀÇ) 1Â÷ ³Ã°¢¼ö )
  • primary education
    ÃÊµî ±³À°
  • primary election
    ¿¹ºñ ¼±°Å
  • primary group
    Á¦ ÀÏÂ÷ Áý´Ü(°¡Á¤,Ä£±¸ µî)
  • primary health worker
    (³óÃÌÀÇ) °£ÀÌ ÀÇ·á º¸Á¶¿ø !
  • primary industry
    1Â÷ »ê¾÷(³ó¸²,¼ö»ê)
  • primary meeting
    ¿¹¼± ´ëȸ;»çÀü ÇùÀÇȸ
  • primary planet
    Ç༺
  • primary producer
    Á¦1Â÷ »ý»êÀÚ(±¤ÇÕ¼º¿¡ ÀÇÇØ ¹«±â¹°¿¡¼­ À¯±â¹°À» »ý»êÇÏ´Â ½Ä¹°)
  • primary production
    1Â÷ »ý»ê(±¤ÇÕ¼º »ý¹°¿¡ ÀÇÇÑ À¯±â¹°ÀÇ »ý»ê)
  • primary products
    ³ó»ê¹°
  • primary root
    ÁÖ±Ù
  • primary school
    ±¹¹ÎÇб³;»ïÇгâ±ÞÀÇ ±¹¹Î Çб³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á